Vironix AI, founded in 2020, is a digital health company based in the United States. It develops AI-powered virtual care management platforms designed for remote monitoring and detection services for patients with chronic conditions.
The company's core product is a comprehensive Virtual Care Management Platform for healthcare providers. This is supported by cellular-enabled medical devices and software applications, including patient mobile apps, to facilitate remote care programs.
The firm's technology operates across the fields of Artificial Intelligence, Digital Health, and Remote Patient Monitoring. Its platforms report measurable outcomes for partner healthcare providers, including a 42% reduction in hospital readmissions, a 35% improvement in patient adherence, and a 58% increase in drug interaction detection.
